»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ PnH5[4&k
}Vfc;2
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨»ù´¡¿Î£©¿ÆÄ¿´úÂ룺806 mOJ-M@ME
s0'6r$xj
Ò»Ãû´Ê½âÊÍ£¨¹²5Ì⣬ÿÌâ4·Ö£¬¹²20·Ö£© 2]E i4%jo
1.Antigen presenting cell£¨APC£© M
%!O)r#Pn
2.Activation induced cell death£¨AICD£© hLaQ[9
3.Chemokine +*G<xW :M
4.Major histocompatibility complex£¨MHC£© A27!I+M
5.immunotolerance EME}G42KN
P}vk5o'
¶þÎÊ´ðÌ⣨¹²5Ì⣬ÿÌâ10·Ö£¬¹²50·Ö£© W(EN01d \
1.ÊÔÊö²ÎÓëThϸ°ûÓëBϸ°ûÏ໥¼¤»îµÄ·Ö×Ó¼°¸÷×ԵŦÄÜ @Py?.H
2.ºÎν𤸽·Ö×Ó£¿¼òÊö𤸽·Ö×ӵķÖÀ༰ÆäÔÚÃâÒßÖеÄ×÷Óà L(}/W~En
3.¼òÊöIIÐͳ¬Ãô·´Ó¦µÄ·¢Éú»úÖÆ 8COGe=+o
4.ÔÚÕý³£Çé¿öÏ£¬ÃâÒßϵͳ¶Ô×ÔÉí¿¹Ô²»²úÉúÃâÒßÓ¦´ðµÄ»úÖÆÊÇʲô£¿ TlC??#
5.±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã 0NXaAf:2Z
?+L7Bd(EF%
ÈýÑ¡´ðÌ⣨µÚ1Ìâ±Ø´ð£¬2ºÍ3ÌâÈÎÑ¡1Ì⣬ÿÌâ15·Ö£¬¹²30·Ö£© !(sL
1.¼òÊöÒÆÖ²ÅųⷴӦÖÐÊÜÕßTϸ°û¶ÔͬÖÖÒìÌ忹ԵÄʶ±ð»úÖÆ¡£Í¨¹ýÖ±½Óʶ±ð¼¤»îµÄÊÜÕßThϸ°ûºÍTcϸ°û·Ö±ðÔÚ¸¨ÖúÊÜÕßBϸ°ûºÍɱÉËÒÆÖ²Îï·½ÃæÓë¼ä½Óʶ±ð¼¤»îµÄThºÍTcÓкβîÒ죿Ϊʲô£¿ >[g.8'hI
2.½áºÏÄãµÄרҵÊÔÊöϸ°ûÒò×ÓÔÚ¼²²¡·¢Éú·¢Õ¹ÖеÄ×÷Óã¬Ä㽫²ÉÈ¡ÄÄЩ²ßÂÔÕë¶ÔÕâЩ°ÐµãÖÎÁƼ²²¡£¿ e'~<uN>
3.ºÎΪ»ùÒò¹¤³Ì¿¹Ì壿Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹£¿ =91f26c!~
9L>ep&u)^
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ Ju_(,M-Vgr
CL5t6D9Qi
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨×¨Òµ¿Î£©¿ÆÄ¿´úÂ룺906 ZBjb f_M:
'
E cd\p
Ò»Ãû´Ê½âÊÍ£¨4·Ö/Ì⣩ d V3R)
1.Antigenic determinant hn e}G._b
2.IgSF AZnFOS
3.MBL;¾¶ C+0BV~7J<<
4.chemokine UbP$WIrq
5.HLA¸´ºÏÌåµÄ¶à»ùÒòÐÔÓë¶àëÄÐÔ :-j/Y'H_
6.TCR-CD3¸´ºÏÎï GX N:=
7.FADD£¨Fas-associated protein with death domain£© 7/bF04~%
8.AIDS `9
1?^T;\F
9.Tumor rejection antigen i7`/"5I
10.AICD FeJKXYbk<
8CRwHDB
¶þÎÊ´ðÌ⣨15·Ö/Ì⣩ JgB"N/Oz
1.¼òÊöCD·Ö×ÓÔÚÃâÒßЧӦÖеÄ×÷Ó㨰´ÊÜÌå·ÖÀà¼òÊö£© LP}j0)n
2.¼òÊöBϸ°û²ÎÓëµÄÃâÒß¹¦ÄÜ bJL ,pe+u
3.¼òÊö×ÔÉíÃâÒßÐÔ¼²²¡Ê±Õë¶Ô×ÔÉí×éÖ¯²úÉúÃâÒßÓ¦´ðµÄ¿ÉÄÜ»úÖÆ ,772$7x
4.ºÎνͬÖÖÒìÐÍMHC¿¹ÔÖ±½Óʶ±ðºÍ¼ä½Óʶ±ð£¿¼òÊöÆäÒì R'aA\k-
5,du2
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¶þÄê¹¥¶Á˶ʿÑо¿ÉúÈëѧÊÔÌâ |k)Nf+(}W
t8Giv89{
UeaHH]U
רҵ¿Î ÃâÒßѧ Ki%RSW(_`
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê G V% @A
1. Immunotoxin 2. T inducer 3. T cell receptor 4. Accessory cell 6"V86b0)h}
5. Fc¦Å receptor 6. Cytokine vVH*\&H\T
¶þ¡¢ ÎÊ´ðÌâ 34qfP{9!N
1. ÃâÒßϵͳÖУ¬ÄÄЩϸ°ûÄÜÌØÒì»ò·ÇÌØÒâÐÔµØÉ±É˰Ðϸ°û£¬ÊÔ·Ö±ð¼òÊöɱÉË×÷ÓõIJ»Í¬Ìص㡣 86~q pN
2. ¸ù¾ÝT¡¢Bϸ°û±íÃæ±êÖ¾µÄ²»Í¬£¬¿ÉÒÔÓ¦ÓÃÄÄЩÃâÒßѧ¼¼Êõ¼ø±ðÕâÁ½Ààϸ°û£¬¼òÊöÓйصÄʵÑéÔÀí£¿ Og"\@n
3. ÔÚIVÐͳ¬Ãô·´Ó¦ÖУ¬ÖÂÃôTϸ°ûÊÍ·ÅÄÄЩÁܰÍÒò×Ó²ÎÓëÃâÒßËðÉË£¬ÏêÊöÆä×÷ÓûúÀí¡£ TL([hR _
4. ÊÔÊöHLA¸´ºÏÌåµÄÒÅ´«Ìص㼰ÕâÐ©ÌØµãµÄÉúÎïѧÒâÒ壿 +qmV|$rmM
5. ºÎνµ¥¿Ë¡¿¹Ì壿ÏêÊöÆäÔÚ»ù´¡ÓëÁÙ´²Ò½Ñ§ÖеÄÓ¦ÓᣠQ}]RB$ZS
ASaNac-3
]ru
U
X
6g'+1%O
e",0Er FT
8#15*'
Y
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÈýÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 41\V;yib
3
~\S]
\rmge4`4
רҵ¿Î ÃâÒßѧ ;Y`k-R:E6A
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê @'FO M
1¡¢ Complement receptor type ¢ñ 2¡¢ Serologically defined antigen be~'}`>
3¡¢ Transfer factor 4¡¢ Immunotoxin 5¡¢ Perforin D,,
x<JG|
6¡¢ Arthus reaction 7¡¢ Network theoty 8.Lymphocyte transformation test *gN)a%9
9. Hybridoma technic 10.Mitogen ]nQ(|$rW
11.Dentritic cell 12.Immunoproliferation ZVz`-hB
¶þ¡¢ »Ø´ðÏÂÁÐÎÊÌâ `r.
1¡¢ ÍÌÊÉϸ°û¶Ôϸ¾úµÄÍÌÊɹý³Ì°üÀ¨ÄöÖ÷Òª½×¶Î£¬ÊÔÏêÊöÖ®¡£ =s1Pf__<k
2¡¢ ÊÔÊöIL-2µÄϸ°ûÀ´Ô´¹¦Äܼ°ÁÙ´²Ó¦Óᣠ)n1 7}Qm`V
3¡¢ Ò©Îï»ò»¯Ñ§ÊÔ¼ÁÒýÆðµÄÒ©ÕîÊôÓÚʲôÐͳ¬Ãô·´Ó¦£¬ÊÔÊöÆä»úÀí¡£ &!O~ f
4¡¢ ÌåÄÚµÄÃâÒß·Ö×Ó°üÀ¨Äļ¸ÀࣿÊÔ¼òÊö¸÷ÀàÃâÒß·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡£ qn~:B7f
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¿ÊÔ·Ö±ð¼òÊöËüÃǵÄÖ÷ÒªÔÀí¡£ Zcxj.F(,
HDT-f9%}<4
%Dm:|><V$b
$#d.@JWi
J
1{ucFa
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅËÄÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ PU^@BZ_m
J9yB'yE8
gPg2Ve0Qy
רҵ¿Î ÃâÒßѧ +~1~f'4J
Ò»¡¢ Ãû´Ê½âÊÍ dNgjM
Q
1¡¢ ³Ù·¢Ðͱä̬·´Ó¦Tϸ°û 2¡¢ C1ÒÖÖÆÎï MuQ'L=i J
3¡¢ ¼¯Âä´Ì¼¤Òò×Ó 4¡¢ ¿¹ÔÌá³Ê×÷Óà *'nZ|r v
5¡¢ HIAÓë¼²²¡µÄ¹ØÁª 6¡¢ Ë«¹¦ÄÜ¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ My JG2C#R
¶þ¡¢ ÎÊ´ðÌâ >PMLjXK
1¡¢ TÁܰÍϸ°û¾ßÓÐÄÄЩ±íÃæ±êÖ¾£¿ÊÔÊö¸÷±íÃæ±êÖ¾µÄÉúÎïѧ×÷Óü°/»òÒâÒå¡£ ##clReS
2¡¢ ÊÔÊöÒÆÖ²ÅųⷴӦµÄÃâÒßÓ¦´ð¹ý³Ì¼°²ÎÓëÅųⷴӦµÄÖÂÃôÁܰÍϸ°ûºÍЧӦÎïÖÊ¡£ R
SqO$~
3¡¢ ºÎνϸ°ûÒò×Ó£¿¼òÊöÆä¹²Í¬Ìص㼰ÓëÁÙ´²µÄ¹ØÏµ¡£ x$Tf IFy
4¡¢ ºÎνÁܰÍϸ°ûÔÓ½»Áö¼¼Êõ£¬ÊÔÊöÆäÔÀí¼°ÒâÒå¡£ O\KSPy7YQ
5¡¢ ºÎνÉúÎïËØ-Ç׺ÍËØÏµÍ³£¿ÊÔÊöÆäÓ¦ÓÃÓÚÃâÒß±ê¼Ç¼¼ÊõµÄÔÀí£¬ÒÔABC·¨ÎªÀý˵Ã÷Ö®¡£ gTjhD
(
;f)o_:(JJ
2%(RB4+
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÎåÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 5D%gDw+"
Wx-vWWx*Q
dw]wQ\4B
רҵ¿Î ÃâÒßѧ mFXkrvOf,
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê sCE2 F_xjL
1¡¢ SmIg 2¡¢ Graft-versus-host reaction GVHR +Jv*u8T'
3¡¢ Immunocompent cell ICC 4¡¢ Tumor-associated antigen TAA =j{r95)|u
5¡¢ Cytokine 6¡¢ Immune tolerance 7¡¢ Biological responsw modifier BRM xRU ~hQ
¶þ¡¢ ÎÊ´ðÌâ l`A4)8Y@
1¡¢ ÃâÒßϵͳÄÚÆðɱÉËЧӦµÄϸ°ûÓÐÄÄЩ£¿ÊÔ¼òÊöÆäɱÉËЧӦµÄÌØµã¡£ )mb RG9P
2¡¢ ºÎν¿¹ÌåµÄ¶àÑùÐÔ£¿¿¹ÌåµÄ¶àÑùÐÔ±íÏÖÔÚÄÄЩ·½Ã棿¼òÊö²úÉú¿¹Ìå¶àÑùÐÔµÄÔÀí¡£ 3JR1If
3¡¢ ÊÔÊö¢òÐÍÓë¢óÐͳ¬Ãô·´Ó¦·¢Éú»úÖÆµÄÒìͬµã¡£ 9x40
4¡¢ ºÎνMHC£¿ÊÔ¼òÊöÆä¹¦ÄÜ¡£ _cW6H B^j
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¬ÒÔø±ê¼Ç¼¼ÊõΪÀý¼òÊöÆäÖ÷ÒªÔÀí¡£ U\\nSU
(&a<6k
bn$}U.m$-
s"solPw
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÁùÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ G]- wN7G
;y{VdT
6b8@6;&LI
רҵ¿Î ÃâÒßѧ >.-$?2
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê njy^<7;
1. IgSF 2. Fc 3. Flow cytometry 4. Adhesion molecule )5Bkm{v3
5. Autogous mixed lymphoyte reaction 0y3<Ho,+$
¶þ¡¢ ÎÊ´ðÌâ F}lgy;=h
1. ÊÔÊöÍâÀ´TD¿¹Ô½øÈë»úÌåÓÕµ¼¿¹Ìå²úÉúµÄÈ«¹ý³Ì¡£ k<M~co;L
2. ºÎνϸ°ûÒò×Ó£¿¼òÊöIL-2µÄ¼ì²â·½·¨¼°ÆäÔÀí¡£ s;0eD5b>x
3. ¼òÊö¿¹¶ÀÌØÐÍÍøÂçµÄµ÷¿Ø×÷ÓᣠCY4_
=
4. ÃâÒßÓ¦´ð¶Ô»úÌåÓкÎÀûº¦¹ØÏµ£¿ 5w#*JK
4
P>tGO&*x
{xC CUU
Y,bw:v
X
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÆßÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ / h6(!-"
wnE
c
@x@
w<e%
רҵ¿Î ÃâÒßѧ sX&M+'h
LaE;{ jY
c#G]3vTdE
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê a .5s5g)8
1. Idiotupe 2. Opsonization 3. Epitope 4. Immunologic tolerance K;f'&9-+i,
5. Delayed type hypersensitivity F GOa!G
¶þ¡¢ ÎÊ´ðÌâ /s%I(iP4
1. ÊÔÊö²¹Ì徵伤»î;¾¶ÓëÅÔ·¼¤»î;¾¶µÄÒìͬ¡£ J{mP5<8>b
2. ¼òÊö¿¹ÌåµÄ»ù±¾½á¹¹£¨ÒÔIgGΪÀý£©Ó빦ÄÜ¡£ sQ^>.yG
3. ¼òÊöHLAÓëҽѧµÄ¹ØÏµ¡£ \QUvImT
4. ÊÔÊöµ¥ºË/¾ÞÊÉϸ°ûÔÚÃâÒßÓ¦´ðÖеÄ×÷Óᣠ@"s\eL,r
5. ¼òÊöÃâÒßÓ¦´ðÖи÷ÖÖÀàÐ͵Äϸ°û¶¾×÷Óᣠ$/C<^}A
R7KQ-+Zb
ABV\:u
dW7dMx
.bl0w"c^qq
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å°ËÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ fC3IxlG
i,")U)b
p 8"(z@T
רҵ¿Î ÃâÒßѧ A2&&iL=j/
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê }WGi9\9T&
1. hypersensitivity 2. cluster of differentiation ~v>w%]
3. adhesion molecules 4. supper antigen 5. split tolerance _ga
!TQ:
¶þ¡¢ ÎÊ´ðÌâ ;(
0:6P8I
1. ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ÓµÄÖ÷ÒªÉúÎïѧ»îÐÔ¡£ 24N,Bo
3
2. ¼òÊöMHC¿¹ÔµÄ·Ö×ӽṹ¼°Æä×éÖ¯·Ö²¼¡£ 9jPb-I-
3. ÊÔÊöÐØÏÙÒÀÀµÐÔ¿¹ÔÒýÆðÌåÒºÃâÒßÓ¦´ðµÄÈ«¹ý³Ì£¨°üÀ¨³õ´ÎÃâÒßÓ¦´ðºÍÔÙ´ÎÃâÒßÓ¦´ð£©¡£ g41
Lh3dj
4. Ϊʲô˵²¹Ì弤»î;¾¶Ö÷Òª²ÎÓëÌìÈ»ÃâÒߣ¿ÊÔÊö²¹ÌåÊÇÈçºÎ¾¹ýÅÔ·;¾¶¶ø±»¼¤»îµÄ¡£ .;KupQ;*
5. Ϊʲô¿¹Ä³Ò»Ï¸°ûÒò×ÓÊÜÌåµÄµ¥¿Ë¡¿¹ÔÌ壬ÓбíÏÖ³öÊÜÌå·â±Õ×÷Ó㬶øÓеÄÔò±íÏÖ³öÊÜÌå´Ì¼¤×÷Óã¿ ,t+ATaOF
.hJ8K#r
8e\v5K9
'c$9[|x
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ dY-a,ch"8p
רҵ¿Î ÃâÒßѧ (x^|
Ò»¡¢ Ãû´Ê½âÊÍ \7j)^
1. ¿¹ÔÐÔ 2. ÃâÒßÇòµ°°×³¬¼Ò×å 3. ¶ÀÌØÐÍ 4. ¿¹Ô¾ö¶¨×å =h_gj >
5. GVHR 2@&|hd=-
¶þ¡¢ ÎÊ´ðÌâ f<;9q?0V F
1. Á½ÖÖ²¹Ì弤»î;¾¶µÄµ÷½ÚÒò×ÓÓÐÄÄЩ£¿±È½ÏËüÃÇÁ½ÖÖ;¾¶ÖеÄ×÷Óᣠ:9h8q"T
2. ¢òÐͳ¬Ãô·´Ó¦µÄ»úÀíÌØµãÊÇʲô£¿¾Ù³öÈý¸ö¢òÐͳ¬Ãô·´Ó¦µÄÀý×Ó¡£ {PVu3W
3. ÊÔÊöϸ°ûÒò×ÓµÄ×÷ÓÃÌØµã¡£ R]Yhuo9,&n
4. Bcell½éµ¼µÄÌåÒºÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ (;j7{(
5. MPSµÄÃâÒßѧ¹¦ÄÜ¡£ 5,c`
lhI;K4#
^`!Daqk
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ }6bLukv
c~'kW`sNV
@
tIB'|O
רҵ¿Î ÃâÒßѧ '
AAY!{>
Ò»¡¢Ãû´Ê½âÊÍ /)I9+s#q9o
1. ÃâÒßÇòµ°°×µÄ¶ÀÌØÐÍ 2. 𤸽·Ö×Ó 3. ÃâÒßÇòµ°°×³¬¼Ò×å 709eLhXrH
4. ¸ÉÈÅËØ 5. HLAµÄ¶à̬ÐÔ 6. ÐØÏÙÒÀÀµÐÔ¿¹Ô 7. ÃâÒßÄÍÊÜ ;9PM?Iy[
8. ËÙ·¢Ðͳ¬Ãô·´Ó¦ 9. µ¥¿Ë¡¿¹Ìå 10. ²¹Ì徵伤»î;¾¶ kUUq9me&o
11. »ìºÏÁܰÍϸ°û·´Ó¦ 12. ÓÐË¿·ÖÁÑ Vw*x3>`
Èý¡¢ ÎÊ´ðÌâ W*<]`U_.
1. ÊÔ¼òÊö¾ÞÊÉϸ°ûÌá³ÊTD¿¹ÔµÄ¹ý³Ì¡£ cBI)?
2. ÊÔ¼òÊöÒÆÖ²ÎËÞÖ÷·´Ó¦µÄ·¢Éú»úÖÆ =vc5,
3. ÊÔÊö²¹ÌåµÄÖ÷ÒªÉúÎïѧ×÷Óà _6m3$k_[MJ
4. ÒÔIgGΪÀý£¬ÊÔÊöÃâÒßÇòµ°°×·Ö×ӵĻù±¾½á¹¹ ~{+{p cO}
5. ÊÔÊöTϸ°ûµÄÖ÷Òª±íÃæ±êÖ¾¼°¹¦ÄÜ Vi#im`@
QVW6SY
<yS"c5D6
A,{D9-%
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ
gn"&/M9E
]uvbQ.l_t
v)yimIHzo
רҵ¿Î ÃâÒßѧ / D ]B
Ò»¡¢Ãû´Ê½âÊÍ ge?-^s4M
1. Ig¶ÀÌØÐÍ 2. SAg 3. 𤸽·Ö×Ó 4. CSF 5. IgSF 6. Tϸ°û»î»¯µÄ´Ì¼¤·Ö×Ó V@:=}*E
7. HLAÓë¼²²¡µÄ¹ØÁª 8. ELISA 9. ÁܰÍϸ°ûµÄ±íÃæ±êÖ¾ udGGDH
Èý¡¢ ÎÊ´ðÌâ
n ;5?^Un%
1. ¼òÊöTÁܰÍϸ°ûµÄ·ÖÀ༰¹¦ÄÜ£¿ (u&yb!`
2. ¼òÊöHLAÍ»±äÌåµÄ»ùÒò×é³É¼°HLAµÄ¹¦ÄÜ£¿ #U52\3G
3. ¼òÊö»úÌå¶ÔÍâÔ´ÐÔ¿¹Ô£¨ÒìÎԣ©µÄ´¦Àí£¬ÈçIgÌá³Ê¹ý³Ì£¿ 2w|u
)ow)
4. ¼òÊö²¹ÌåÁ½ÖÖ¼¤»î;¾¶µÄ»ù±¾¹ý³Ì£¬²¢±È½Ï¶þÕßÒìͬ£¿ ;lH,bX~5
5. ¼òÊöAIDSÖÐCD4+ϸ°û¼õÉٵĻúÖÆ£¿ rp#*uV9;
htYrv5q=M
m]d6@"Z.
?gwbg*
pE/3-0;}N
99Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ rg^\BUa-W,
Ò»¡¢Ãû´Ê½âÊÍ q>(u>z!
2¡¢ HLAµÄ¶à̬ÐÔ 3¡¢ 𤸽·Ö×Ó 4¡¢ ¶ÀÌØÐÍ 5¡¢ ¿¹ÔëÄתÔËÎï [y[
v]'
6¡¢ Ig³¬¼Ò×å 7¡¢ µòÍö 8¡¢ ÓÐË¿·ÖÁÑÔ 9¡¢ CD4·Ö×Ó [l%fL9
10¡¢ ³¬Ãô·´Ó¦ 11¡¢ ×ÔÉíÃâÒß²¡ (vsk^3R[6
¶þ¡¢ ÎÊ´ðÌâ E'S;4B5?
1¡¢ ÊÔÊöÍâÔ´ÐÔ¿¹ÔºÍÄÚÔ´ÐÔ¿¹ÔÌá³ÊµÄ¹ý³Ì¡£ wu!_BCIy
2¡¢ ÊÔÊöBϸ°û½éµ¼µÄÔÙ´ÎÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ uxMy1oy
3¡¢ ÊÔÊö·Ö×ÓˮƽµÄÃâÒßµ÷½Ú¡£ y8*@dRrq
4¡¢ ÊÔÊö»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÕ÷£¨AIDS£©µÄ·¢²¡»úÖÆ¡£ bC4*w
O
7R<u=U
2000Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ 0SCW2/o8
Ò»¡¢ Ãû´Ê½âÊÍ ooU Sb
1¡¢ µ÷Àí×÷Óà 2¡¢ 𤸽·Ö×Ó 3¡¢ ³¬¿¹Ô 4¡¢ ÃâÒßȱÏݲ¡ w4fJ`,
5¡¢ FasÓëFasL 6¡¢ µ¥¿Ë¡¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ ,gL)~6!A
8¡¢ ÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£© 9¡¢ Ö×ÁöÏà¹Ø¿¹Ô£¨TAA£© iWN.3|r
10¡¢ ÒõÐÔÑ¡Ôñ w
HHF=Q
¶þ¡¢ ÎÊ´ðÌâ ]i,Mq
1¡¢ ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ӵĹ²Í¬Ìص㣿 5lHN8k=mm2
2¡¢ ºÎνAPC¼°ÆäÖÖÀࣿ¼òÊöÍâÔ´ÐÔ¿¹ÔµÄÈÜøÌåÌá³Ê;¾¶£¿ 8~s-t
3¡¢ ¼òÊöϸ°ûÃâÒßÓ¦´ðµÄÁ½ÀàЧӦϸ°ûµÄЧӦ»úÖÆ£¿Ï¸°ûÃâÒßµÄÉúÎïѧÒâÒ壿 U8QR*"GmT
4¡¢ ºÎνMHC£¿¼òÊöMHCµÄ¹¦ÄÜ£¿ JM+sHHs
5¡¢ ºÎν×ÔÉíÃâÒß²¡£¿¼òÊö×ÔÉíÃâÒß²¡µÄ×éÖ¯ËðÉË»úÖÆ£¿. ttbQergS
i_9Cc$Qh<
g=oeS%>E
# McK46B z
ͬ¼ÃÒ½¿Æ´óѧ2000Äê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ Bgk~R.l
3vRLg b
TM/|K|_
רҵ¿Î ÃâÒßѧ @ yg|OA}
Ò»¡¢½«ÏÂÁÐÓ¢Óïµ¥´Ê·Òë³ÉÖÐÎIJ¢Ãû´Ê½âÊÍ vSYunI
1. Cytokines 2. adhesion molecules 3. graft versus host reaction i^yH?bH @~
4. immunologic tolerance 5. Opsonization G&%nF4
Èý¡¢ ÎÊ´ðÌâ -
5o<Q'(
1. ʲôÊÇMHC£¿ÊÔÊöMHC-¢òÀà·Ö×ӵĽṹ¡¢¸÷²¿Î»¹¦ÄÜ£¬MHC-¢òÀà·Ö×ÓµÄ×éÖ¯·Ö²¼¼°ÆäÃâÒßѧ×÷Óᣠ<i:*p1#Bm
2. ÓÐÄÄÈý´ú¿¹Ì壿ÊÔÊö¿¹Ì壨IgG£©µÄ»ù±¾½á¹¹¡¢¸÷²¿Î»¹¦Äܼ°ÕâÈý´ú¿¹ÌåµÄÌØÐÔ¡£
'XP>} m
3. ʲôÊÇ×ÔÉíÃâÒß²¡£¿ÊÔÊöÆä·¢²¡»úÖÆ¡£ %2Xus9;k#
4. ÃâÒßϵͳɱÉ˰Ðϸ°ûµÄ·½Ê½¼°ÏàӦϸ°ûºÍ·Ö×ÓÓÐÄÄЩ£¿ÊÔÊöTc½éµ¼µÄϸ°ûÃâÒßÓ¦´ð¡£ P^K?E
5. »úÌåµÄÃâÒßϵͳΪʲô¿ÉÒÔʶ±ð×Ô¼ººÍÒ켺£¿ÆäÖ÷Òª»úÖÆÊÇʲô£¿ Z0()pT
y(/jTS/hd
W2F+^
KlVi4.]
BGlGpl
vDK
:v$g
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ u_}`
y1Xu#
PS_3Oq)
{2}tPT[a(
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧרҵ¿Î¿¼ÊÔÊÔÌâ 2A*X Hvwb
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ m0xJ05Zx
Ò»¡¢ ½âÊÍÏÂÁÐÃû´Ê Eu`2w%qz
1. C3b½éµ¼µÄµ÷Àí×÷Óà 2.Tϸ°û¼¤»îµÄµÚ¶þÐźÅ3.Th1ϸ°û 4.HLAµÄ¶à̬ÐÔ L~*|,h
5.C1ÒÖÖÆÎï 6.TCR¦Ã¦ÄTϸ°û7.³Ù·¢Ðͳ¬Ãô·´Ó¦ 8.Ç÷»¯ÐÔϸ°ûÒò×Ó9.ÃâÒßÇòµ°°×µÄÀà±ðת»¯ 10.ÔìѪ¸Éϸ°û b"ol\&1
#
11.»î»¯ÓÕµ¼µÄϸ°ûËÀÍö LPq*ZZK
¶þ¡¢ Çë»Ø´ðÏÂÁÐÎÊ´ð ^ [X|As2
1. ºÎνµ¥¿Ë¡¿¹Ì壬¼òÊöÆäÖÆ±¸ÔÀí¡£ )CC?vV
2. ¼òÊöTϸ°ûÔÚÐØÏÙÄڵķ¢Óý¹ý³Ì¡£ {f`lSu
3. ÃâÒßϸ°û±íÃæÖ÷ÒªÓÐÄļ¸Àà±íÃæ¿¹ÔºÍ±íÃæÊÜÌ壬¼òÊö¸÷Àà·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡££¨HLA¡¢CD¡¢AM¡¢CKR¡¢CR¡¢MitogenR¡¢TCR¡¢BCR¡¢FcR£© 8N=%X-R%
4. ÊԱȽÏTCR¸´ºÏÌåºÍBCR¸´ºÏÌå½á¹¹Ó빦ÄܵÄÒìͬ¡£ %+AS0 JhB
5. ÊԱȽϳ¬¿¹ÔÓëÆÕͨ¿¹ÔµÄÒìͬ¡£ +8LM~voB
7.wR"1p#
o|z
+!,
>:w?qEaE
*A~($ZtL
P1(8U%
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ :[y]p7;{f
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧµ¥¶À¿¼ÊÔÊÔÌâ ePV-yy
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ jo 7Hyw!g
-rEeKt
Ò»¡¢ Ãû´Ê½âÊÍ IY];Ss&i
1. ¿¹Ô³ÊµÝ 2. µ÷Àí×÷Óà 3. ³Áµí·´Ó¦ 4. ×ÔÉíÃâÒß ((Vj]I%
;
5. GVHR 6. ÔìѪ¸Éϸ°û 7. ¿Ë¡ѡÔñѧ˵ 8. Ir»ùÒò #=X)Jx~
9. ³¬Ãô·´Ó¦ 10. ³¬¿¹Ô Y*5Z)h
1
¶þ¡¢ÎÊ´ðÌâ >}-~rZ
11. ¼òÊö²¹ÌåµÄÅÔ·¼¤»î;¾¶ %)zk..K{l
12. ¼òÊöT¡¢Bϸ°ûÌØÕ÷µÄ²îÒì Na\3.:]z
13. ¼òÊöT¡¢Bϸ°û¿¹Ô¾ö¶¨´ØµÄ²îÒì VYL@RL'
14. ΪʲôÃâÒßÇòµ°°×¾ßÓп¹ÔÐÔ£¿ÊÔÊöÃâÒßÇòµ°°×µÄ¿¹ÔÐÔ¡£ ?RZq =5Um&
15. ʲôÊÇÖ×Áö¿¹Ô£¿ÊÔÊö»úÌåÕë¶ÔÖ×Áö¿¹Ô²úÉú¿¹Ö×ÁöÃâÒßÓ¦´ðµÄ»úÖÆ¡£ _aVJ$N.
IM@"AD52a